pyrroles has been researched along with pituitrin in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (10.00) | 18.7374 |
| 1990's | 4 (13.33) | 18.2507 |
| 2000's | 17 (56.67) | 29.6817 |
| 2010's | 6 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, H; Kodama, K; Ogawa, T; Ohhara, H | 1 |
| Cavero, I; Hyman, A; Le Monnier de Gouville, AC; Lippton, H; Mondot, S | 1 |
| Altes, U; Baur, AM; Hobbach, HP; Jost, D; Racké, K; Schäfer, J; Wammack, R | 1 |
| Buckingham, RE | 1 |
| Goreczky, L; Róth, I | 1 |
| Coleman, R; Roma, MG; Shaw, R; Stone, V | 1 |
| Ezure, Y; Hasegawa, H; Kawano, K; Matsukawa, H; Morizono, D; Naito, A; Naito, K; Oguma, T; Ohtake, Y; Tanaka, Y; Taniguchi, M; Tsuriya, Y | 1 |
| Gross, P; Palm, C | 1 |
| Kitano, M; Matsui, K; Ohashi, N; Sasabe, M; Yamamoto, S | 1 |
| Imaki, J; Imaki, T; Katsumata, H; Minami, S; Miyata, M; Naruse, M | 1 |
| Arieff, AI | 1 |
| Martinez-Castelao, A | 1 |
| Matsui, K; Ohashi, N; Sasabe, M; Yamamoto, S | 1 |
| Ellis-Grosse, EJ; Guyader, D; Orczyk, GP; Patat, A | 1 |
| Ferguson, JW; Hayes, PC; Newby, DE; Therapondos, G | 1 |
| Ma, S; Morilak, D; Russell, JA; Shipston, MJ | 1 |
| Gheorghiade, M; Orlandi, C; Zimmer, CA | 1 |
| Greenberg, A; Verbalis, JG | 1 |
| Kamyar, M; Lemmens-Gruber, R | 1 |
| Gross, P; Herbrig, K; Palm, C; Pistrosch, F | 1 |
| Kumar, S; Mather, PJ; Rubin, S; Whellan, DJ | 1 |
| Hobbs, RE; Tang, WH | 1 |
| Laczi, F | 1 |
| Bech, JN; Holst, LM; Paulsen, L; Pedersen, EB; Starklint, J | 1 |
| Reilly, T; Schork, MR | 1 |
| Singh, M; Slawsky, MT; Valania, G | 1 |
| Villabona, C | 1 |
| Bech, JN; Hansen, AB; Jensen, JM; Larsen, T; Mose, FH; Pedersen, EB | 1 |
| Hou, L; Li, Q; Liu, Z; Zhang, G; Zhang, M; Zhang, X; Zhou, X; Zhu, L | 1 |
| Mori-Kawabe, M; Tsushima, H | 1 |
14 review(s) available for pyrroles and pituitrin
| Article | Year |
|---|---|
The treatment of hyponatraemia using vasopressin antagonists.
Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Humans; Hyponatremia; Morpholines; Pyrroles; Receptors, Vasopressin; Spiro Compounds; Vasopressins | 2000 |
Treatment of hyponatremic encephalopathy with antagonists to antidiuretic hormone.
Topics: Azepines; Benzamides; Brain Diseases, Metabolic; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Pyrroles; Vasopressins | 2001 |
Lixivaptan (American Home Products).
Topics: Animals; Azepines; Benzamides; Clinical Trials as Topic; Humans; Hyponatremia; Pyrroles; Structure-Activity Relationship; Vasopressins | 2001 |
Therapeutic role of vasopressin receptor antagonism in patients with liver cirrhosis.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Controlled Clinical Trials as Topic; Diuretics; Heart Failure; Homeostasis; Humans; Inappropriate ADH Syndrome; Liver Cirrhosis; Models, Animal; Morpholines; Piperidines; Pyrroles; Quinolones; Rats; Spiro Compounds; Vasopressins | 2003 |
Role of vasopressin antagonists in the management of acute decompensated heart failure.
Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Heart Failure; Humans; Pyrroles; Stroke Volume; Tolvaptan; Treatment Outcome; Vasoconstriction; Vasopressins | 2005 |
Vasopressin receptor antagonists.
Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Clinical Trials as Topic; Diabetes Insipidus, Nephrogenic; Fibrosis; Heart Failure; Humans; Hyponatremia; Osmolar Concentration; Polycystic Kidney Diseases; Pyrroles; Receptors, Vasopressin; Sodium; Tolvaptan; United States; United States Food and Drug Administration; Vasopressins | 2006 |
Vasopressin antagonists.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Binding Sites; Cardiovascular Diseases; Clinical Trials as Topic; Hormone Antagonists; Humans; Indoles; Pyrroles; Pyrrolidines; Tolvaptan; Vasopressins; Water-Electrolyte Imbalance | 2006 |
Vasopressin antagonists as aquaretic agents for the treatment of hyponatremia.
Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Humans; Hyponatremia; Inappropriate ADH Syndrome; Morpholines; Pyrroles; Randomized Controlled Trials as Topic; Spiro Compounds; Tolvaptan; Vasopressins | 2006 |
Hyponatremia and vasopressin antagonism in congestive heart failure.
Topics: Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Chronic Disease; Clinical Trials as Topic; Diuretics; Heart Failure; Humans; Hyponatremia; Models, Biological; Pyrroles; Registries; Renin-Angiotensin System; Sodium; Tolvaptan; Treatment Outcome; Vasopressins | 2007 |
Vasopressin receptor antagonists in heart failure.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Heart Failure; Humans; Pyrroles; Receptors, Vasopressin; Tolvaptan; Vasopressins | 2006 |
[Etiology, diagnostics and therapy of hyponatremias].
Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Blood Volume; Brain Diseases; Central Nervous System; Chronic Disease; Demeclocycline; Demyelinating Diseases; Diagnosis, Differential; Diuretics; Extracellular Fluid; Furosemide; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lithium Compounds; Morpholines; Osmolar Concentration; Osmosis; Pyrroles; Severity of Illness Index; Sodium; Spiro Compounds; Time Factors; Tolvaptan; Vasopressins | 2008 |
Vasopressin antagonists: Pharmacotherapy for the treatment of heart failure.
Topics: Azepines; Benzamides; Benzazepines; Heart Failure; Humans; Hyponatremia; Neurotransmitter Agents; Pyrroles; Tolvaptan; Vasopressins | 2010 |
Targeting hyponatremia and hemodynamics in acute decompensated heart failure: is there a role for vasopressin antagonists?
Topics: Acute Disease; Animals; Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Clinical Trials as Topic; Heart Failure; Hemodynamics; Humans; Hyponatremia; Prognosis; Pyrroles; Tolvaptan; Vasoconstriction; Vasopressins | 2011 |
[Vasopressin receptor antagonists: the vaptans].
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Benzamides; Benzazepines; Calcium Signaling; Clinical Trials as Topic; Cyclic AMP; Double-Blind Method; Drug Therapy, Combination; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Kidney Tubules, Collecting; Liver Cirrhosis; Morpholines; Multicenter Studies as Topic; Neoplasms; Pituitary Gland, Anterior; Pyrroles; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Second Messenger Systems; Spiro Compounds; Tolvaptan; Vasopressins | 2010 |
3 trial(s) available for pyrroles and pituitrin
| Article | Year |
|---|---|
Pharmacodynamic effects of a nonpeptide antidiuretic hormone V2 antagonist in cirrhotic patients with ascites.
Topics: Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Ascites; Azepines; Benzamides; Double-Blind Method; Drinking; Electrolytes; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Osmolar Concentration; Pyrroles; Renin; Sodium; Urine; Urodynamics; Vasopressins; Water; Water-Electrolyte Balance | 2002 |
Glomerular filtration rate and blood pressure are unchanged by increased sodium intake in atorvastatin-treated healthy men.
Topics: Adult; Aldosterone; Angiotensin II; Aquaporin 2; Atorvastatin; Atrial Natriuretic Factor; Blood Pressure; Female; Glomerular Filtration Rate; Heptanoic Acids; Humans; Kidney Function Tests; Lithium; Male; Natriuretic Peptide, Brain; Pyrroles; Renin; Sodium; Vasopressins | 2009 |
Effect of atorvastatin on renal NO availability and tubular function in patients with stage II-III chronic kidney disease and type 2 diabetes.
Topics: Aged; Arginine Vasopressin; Atorvastatin; Atrial Natriuretic Factor; Blood Pressure; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glomerular Filtration Rate; Heart Rate; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Tubules; Male; Middle Aged; Natriuretic Peptide, Brain; Nitric Oxide; omega-N-Methylarginine; Pulse Wave Analysis; Pyrroles; Renal Insufficiency, Chronic; Treatment Outcome; Vascular Stiffness; Vasopressins | 2014 |
13 other study(ies) available for pyrroles and pituitrin
| Article | Year |
|---|---|
Inhibitory effect of a novel antianginal agent, E4080, on ST segment elevation induced by vasopressin in anesthetized guinea pigs.
Topics: Anesthesia; Animals; Benzopyrans; Cardiovascular Agents; Catechols; Clonidine; Coronary Vessels; Cromakalim; Electrocardiography; Guinea Pigs; Heart Rate; Imidazoles; In Vitro Techniques; Isosorbide Dinitrate; Male; Nifedipine; Pyrroles; Vasodilator Agents; Vasopressins | 1992 |
Hemodynamic and pharmacological evaluation of the vasodilator and vasoconstrictor effects of endothelin-1 in rats.
Topics: Animals; Benzopyrans; Blood Pressure; Cromakalim; Drug Tolerance; Endothelins; Endothelium, Vascular; Hemodynamics; Imidazoles; In Vitro Techniques; Male; Nitrendipine; Peptides; Potassium Channels; Pyrroles; Rats; Rats, Inbred SHR; Tachyphylaxis; Vasoconstriction; Vasodilation; Vasopressins | 1990 |
Differential effects of potassium channel blockers on neurohypophysial release of oxytocin and vasopressin. Evidence for frequency-dependent interaction with the endogenous opioid inhibition of oxytocin release.
Topics: 4-Aminopyridine; Amifampridine; Aminopyridines; Animals; Benzopyrans; Cromakalim; Electric Stimulation; Endorphins; Female; Naloxone; Oxytocin; Pituitary Gland, Posterior; Potassium Channels; Pyrroles; Radioimmunoassay; Rats; Rats, Inbred Strains; Tetraethylammonium; Tetraethylammonium Compounds; Vasopressins | 1988 |
Studies on the anti-vasoconstrictor activity of BRL 34915 in spontaneously hypertensive rats; a comparison with nifedipine.
Topics: Angiotensin II; Animals; Benzopyrans; Blood Pressure; Cromakalim; Dose-Response Relationship, Drug; Female; Hypertension; Infusions, Intravenous; Nifedipine; Norepinephrine; Phenylephrine; Pyrroles; Rats; Rats, Inbred SHR; Vasoconstriction; Vasopressins | 1988 |
[Regulatory disturbances in acute intermittent porphyria and lead poisoning].
Topics: Enzyme Induction; Growth Hormone; Humans; Hydro-Lyases; Hypothalamo-Hypophyseal System; Lead Poisoning; Levulinic Acids; Melanocyte-Stimulating Hormones; Porphyrias; Propionates; Pyrroles; Thyrotropin; Vasopressins; Water-Electrolyte Balance | 1969 |
Vasopressin-induced disruption of actin cytoskeletal organization and canalicular function in isolated rat hepatocyte couplets: possible involvement of protein kinase C.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Actins; Animals; Antioxidants; Bile Canaliculi; Bucladesine; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Carbazoles; Cells, Cultured; Chelating Agents; Cyclic AMP-Dependent Protein Kinases; Cytoskeleton; Egtazic Acid; Enzyme Activation; Enzyme Inhibitors; Imidazoles; Indoles; Leupeptins; Liver; Male; Microscopy, Electron, Scanning; Phorbol 12,13-Dibutyrate; Protein Kinase C; Pyrroles; Rats; Rats, Wistar; Tight Junctions; Vacuoles; Vasopressins | 1998 |
Novel vasopressin V2 receptor-selective antagonists, pyrrolo[2,1-a]quinoxaline and pyrrolo[2,1-c][1,4]benzodiazepine derivatives.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzodiazepines; Diuresis; Diuretics; In Vitro Techniques; Pyrroles; Quinoxalines; Rats; Structure-Activity Relationship; Vasopressins | 1999 |
Effect of SMP-300, a new Na+/H+ exchange inhibitor, on myocardial ischemia and experimental angina models in rats.
Topics: Amiloride; Angina Pectoris; Animals; Azocines; Blood Pressure; Disease Models, Animal; Electrocardiography; Heart; Heart Rate; Isoproterenol; Male; Myocardial Ischemia; Myocardium; Neuroprotective Agents; Pyrroles; Rats; Rats, Sprague-Dawley; Sodium-Hydrogen Exchangers; Vasopressins | 2000 |
Expression of corticotropin-releasing hormone type 1 receptor in paraventricular nucleus after acute stress.
Topics: Adrenocorticotropic Hormone; Animals; Corticotropin-Releasing Hormone; Gene Expression; In Situ Hybridization; Male; Oxytocin; Paraventricular Hypothalamic Nucleus; Proto-Oncogene Proteins c-fos; Pyrimidines; Pyrroles; Rats; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone; RNA, Messenger; Stress, Physiological; Vasopressins | 2001 |
Effect of an orally active Na+/H+ exchange inhibitor, SMP-300, on experimental angina and myocardial infarction models in rats.
Topics: Administration, Oral; Angina Pectoris; Animals; Azocines; Coronary Disease; Electrocardiography; Isoproterenol; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nicorandil; Nifedipine; Propranolol; Pyrroles; Rats; Rats, Sprague-Dawley; Rats, Wistar; Sodium-Hydrogen Exchangers; Vasodilator Agents; Vasopressins | 2002 |
Reduced hypothalamic vasopressin secretion underlies attenuated adrenocorticotropin stress responses in pregnant rats.
Topics: Adrenocorticotropic Hormone; Animals; Dose-Response Relationship, Drug; Female; Hypothalamus; In Situ Hybridization; Pregnancy; Pregnancy, Animal; Pro-Opiomelanocortin; Pyrimidines; Pyrroles; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Receptors, Vasopressin; RNA, Messenger; Time Factors; Vasopressins | 2005 |
Participation of Antidiuretic Hormone (ADH) in Asthma Exacerbations Induced by Psychological Stress via PKA/PKC Signal Pathway in Airway-Related Vagal Preganglionic Neurons (AVPNs).
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Asthma; Carbazoles; Cyclic AMP-Dependent Protein Kinases; Cytokines; Disease Models, Animal; Eosinophils; Female; Mice; Mice, Inbred BALB C; Morpholines; Neurons; Ovalbumin; Protein Kinase C; Protein Kinase Inhibitors; Pyrroles; Receptors, Vasopressin; Signal Transduction; Spiro Compounds; Stress, Psychological; Vasopressins | 2017 |
Central Transient Receptor Potential Vanilloid 4 Contributes to Systemic Water Homeostasis through Urinary Excretion.
Topics: Animals; Atrial Natriuretic Factor; Dinoprost; Diuresis; Drinking; Homeostasis; Indomethacin; Male; Morpholines; Phorbol Esters; Pyrroles; Rats; Rats, Wistar; Ruthenium Red; TRPV Cation Channels; Urination; Vasopressins | 2019 |